Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Indraprastha Medical

₹240.4 0.5 | 0.2%

Market Cap ₹2204 Cr.

Stock P/E 19.6

P/B 5

Current Price ₹240.4

Book Value ₹ 48.5

Face Value 10

52W High ₹282.5

Dividend Yield 1.25%

52W Low ₹ 81.6

Indraprastha Medical Research see more...

Overview Inc. Year: 1988Industry: Hospital & Healthcare Services

Indraprastha Medical Corporation Ltd is an India-based company, that is engaged in the healthcare business. The predominant enterprise of the Company is to provide comprehensive hospital services. It operates approximately 4000 pharmacies across India.

Read More..

Indraprastha Medical Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Indraprastha Medical Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 233 237 216 263 284 277 274 307 317 306
Other Income 0 1 2 1 1 3 5 4 4 4
Total Income 233 237 218 264 286 280 279 310 321 311
Total Expenditure 208 205 188 226 241 240 241 259 267 259
Operating Profit 26 32 29 38 45 40 38 51 55 52
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 9 9 9 10 10 10 10 10 10 10
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 16 22 20 27 34 29 27 40 44 41
Provision for Tax 4 6 5 7 9 9 7 10 11 11
Profit After Tax 12 16 15 20 25 21 20 31 33 29
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 12 16 15 20 25 21 20 31 33 29
Adjusted Earnings Per Share 1.3 1.7 1.7 2.2 2.7 2.3 2.2 3.3 3.6 3.2

Indraprastha Medical Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 607 678 714 755 766 753 788 831 613 888 1099 1204
Other Income 1 1 1 2 0 1 0 1 1 3 10 17
Total Income 608 679 715 758 766 753 789 831 614 891 1109 1221
Total Expenditure 528 587 630 676 687 680 707 744 573 774 948 1026
Operating Profit 80 92 86 81 79 74 81 87 41 117 161 196
Interest 9 10 8 7 8 9 7 6 3 3 4 4
Depreciation 26 28 28 35 31 31 30 33 33 35 39 40
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 45 54 50 39 41 34 45 48 4 79 117 152
Provision for Tax 17 19 17 14 15 13 16 5 2 20 31 39
Profit After Tax 29 35 32 24 26 21 28 44 2 59 86 113
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 29 35 32 24 26 21 28 44 2 59 86 113
Adjusted Earnings Per Share 3.1 3.9 3.5 2.7 2.9 2.3 3.1 4.8 0.3 6.4 9.4 12.3

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 24% 10% 8% 6%
Operating Profit CAGR 38% 23% 17% 7%
PAT CAGR 46% 25% 33% 11%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 187% 41% 45% 20%
ROE Average 24% 15% 15% 15%
ROCE Average 34% 22% 21% 20%

Indraprastha Medical Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 171 187 195 224 231 232 244 268 273 325 379
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 30 26 11 2 0 21 15 0 0 0 0
Other Non-Current Liabilities 41 44 42 44 42 41 39 42 43 43 46
Total Current Liabilities 196 192 194 191 186 138 124 140 116 94 130
Total Liabilities 438 449 442 460 458 432 422 449 432 462 555
Fixed Assets 300 293 286 301 296 294 280 303 283 277 275
Other Non-Current Assets 6 8 7 7 5 5 7 5 7 27 57
Total Current Assets 132 147 149 152 158 133 136 141 141 157 223
Total Assets 438 449 442 460 458 432 422 449 432 462 555

Indraprastha Medical Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 1 2 2 3 2 2 3 17 20 25 42
Cash Flow from Operating Activities 67 58 64 62 28 48 75 86 27 94 144
Cash Flow from Investing Activities -54 -22 -29 -33 -22 -30 -17 -40 -19 -74 -108
Cash Flow from Financing Activities -13 -36 -35 -30 -5 -17 -44 -43 -3 -3 -26
Net Cash Inflow / Outflow 0 0 -0 -0 -0 1 14 4 5 17 11
Closing Cash & Cash Equivalent 2 2 2 2 2 3 17 20 25 42 52

Indraprastha Medical Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 3.14 3.87 3.54 2.67 2.86 2.3 3.1 4.76 0.25 6.39 9.4
CEPS(Rs) 5.96 6.94 6.62 6.52 6.19 5.65 6.35 8.36 3.89 10.21 13.68
DPS(Rs) 1.6 1.8 1.8 1.8 1.8 1.5 1.6 0 0 2.5 3
Book NAV/Share(Rs) 18.65 20.41 21.25 24.41 25.18 25.34 26.62 29.21 29.75 35.5 41.39
Core EBITDA Margin(%) 12.95 13.41 11.88 10.51 10.29 9.67 10.25 10.4 6.57 12.87 13.72
EBIT Margin(%) 8.92 9.4 8.07 6.11 6.36 5.7 6.53 6.51 1.24 9.29 11.06
Pre Tax Margin(%) 7.5 7.99 6.93 5.13 5.33 4.52 5.66 5.8 0.7 8.9 10.67
PAT Margin (%) 4.74 5.23 4.55 3.23 3.43 2.8 3.6 5.25 0.38 6.6 7.84
Cash Profit Margin (%) 9.01 9.38 8.49 7.91 7.41 6.88 7.38 9.22 5.81 10.53 11.42
ROA(%) 6.85 7.99 7.3 5.42 5.71 4.74 6.65 10.01 0.53 13.12 16.94
ROE(%) 17.42 19.79 17.02 11.68 11.55 9.11 11.93 17.05 0.86 19.6 24.44
ROCE(%) 22.98 25.78 23.29 17.72 16.98 14.4 18.29 20.15 2.8 27.58 34.46
Receivable days 25.55 31.48 36.3 39.26 43.64 44.32 37.2 34.13 43.6 22.75 18.54
Inventory Days 6.62 6.48 6.35 5.32 4.65 4.62 4.04 4.48 6.19 3.85 3.06
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 10.44 10.05 15.69 19.49 18.53 20.98 12.37 7.13 211.45 9.14 8.27
Price/Book(x) 1.76 1.9 2.62 2.13 2.11 1.91 1.44 1.16 1.81 1.65 1.88
Dividend Yield(%) 4.89 4.63 3.24 3.46 3.39 3.11 4.17 0 0 4.28 3.86
EV/Net Sales(x) 0.61 0.61 0.78 0.69 0.71 0.66 0.44 0.35 0.76 0.53 0.53
EV/Core EBITDA(x) 4.61 4.5 6.45 6.41 6.9 6.8 4.31 3.34 11.36 3.98 3.63
Net Sales Growth(%) 16.3 11.68 5.44 5.74 1.36 -1.71 4.72 5.4 -26.17 44.8 23.7
EBIT Growth(%) 17.95 17.76 -9.5 -19.92 5.53 -11.94 20.02 5.08 -85.9 981 47.26
PAT Growth(%) 6.55 23.19 -8.31 -24.8 7.42 -19.59 34.64 53.54 -94.66 2415.88 46.96
EPS Growth(%) 6.55 23.19 -8.31 -24.8 7.42 -19.59 34.64 53.54 -94.66 2415.62 46.96
Debt/Equity(x) 0.43 0.34 0.26 0.23 0.29 0.28 0.09 0.01 0 0 0
Current Ratio(x) 0.67 0.77 0.77 0.8 0.85 0.96 1.09 1.01 1.22 1.68 1.72
Quick Ratio(x) 0.61 0.7 0.7 0.75 0.8 0.89 1.03 0.93 1.14 1.58 1.66
Interest Cover(x) 6.28 6.67 7.11 6.22 6.16 4.82 7.49 9.14 2.28 24.19 28.38
Total Debt/Mcap(x) 0.24 0.18 0.1 0.11 0.14 0.15 0.06 0.01 0 0 0

Indraprastha Medical Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 51 51 51 51 51 51 51 51 51 51
FII 0.18 0.14 0.09 0.15 0.77 0.27 0.37 0.8 0.95 1.08
DII 0.02 0.02 0.02 0.02 0 0 0 6.71 6.37 4.91
Public 48.8 48.84 48.89 48.83 48.22 48.72 48.62 41.49 41.68 43.01
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company has delivered good profit growth of 32% CAGR over last 5 years
  • Company is almost debt free.

Cons

  • Stock is trading at 5 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Indraprastha Medical News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....